Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in October 2011.
It was funded by China major scientific and technological specialized project for 'significant new formulation of new drugs'.
Shenfu is kind of Chinese Medicine injection used for treating shock and coronary heart disease in many Chinese hospitals.
The purpose of this study is to determine adverse drug events or adverse drug reaction in large sample size 20,000 patients.
Safety surveillance on Chinese Medicine injection is an important problem that needs to be sorted out ,because in mainland China hospitals ,Chinese Medicine Injection are used widely. Population for taking medicine characteristics,the incidence rate of ADR and other uncertain factors influence can not be found now.
A registry study for Shenfu injection safety surveillance with 20000 patients will be conducted from Jan.2012 to Dec.2015.
Eligibility criteria Patients who will use Shenfu injection in selected hospitals.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with adverse events; incidence of Shenfu'ADRs and identify factors that contributed to the occurrence of the adverse reaction. | The registry procedure will last 3 years only for patients using Shenfu. |
Not provided
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
An anticipated sample size was caculated in this study, about 20000. Patients using Shenmai injection from 2012 to 2014 in 15 hospitals.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yan M Xie, BA | Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences | Principal Investigator |
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jul 26, 2016 | |
| Unrelease | Yes | |
| Release | Jul 29, 2016 | |
| Reset | Sep 16, 2016 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jul 26, 2016 | Yes | |||
| Jul 29, 2016 |
| ID | Term |
|---|---|
| D012769 | Shock |
| D003327 | Coronary Disease |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Sep 16, 2016 |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |